GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
Series GSE126281 Query DataSets for GSE126281
Status Public on Feb 13, 2019
Title Type I Interferon Delivery by iPSC-Derived Myeloid Cells Elicits Antitumor Immunity via XCR1+ Dendritic Cells
Organism Mus musculus
Experiment type Expression profiling by high throughput sequencing
Summary This SuperSeries is composed of the SubSeries listed below.
Overall design Refer to individual Series
Citation missing Has this study been published? Please login to update or notify GEO.
Submission date Feb 08, 2019
Last update date Mar 21, 2019
Contact name Ranmaru Shimoda
Phone +818043368250
Organization name Rhelixa, Inc.
Street address 3F Yayoi Bldg., 3-7-4 Iwamotocho
City Chiyoda
State/province Tokyo
ZIP/Postal code 101-0032
Country Japan
Platforms (2)
GPL16417 Illumina MiSeq (Mus musculus)
GPL17021 Illumina HiSeq 2500 (Mus musculus)
Samples (32)
GSM3595651 pMC_01
GSM3595652 pMC_02
GSM3595653 IFN-alpha-pMC_01
This SuperSeries is composed of the following SubSeries:
GSE126277 IFN-α-producing proliferating myeloid cells reveal type I IFN-stimulating gene signature
GSE126278 Characterization of tumor-infiltrating T cells by TCR-β repertoire analyses
GSE126279 Local administration of IFN-α-iPSC-pMCs alters gene expression profiles in tumor microenvironment.
BioProject PRJNA521782

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE126281_RAW.tar 7.5 Mb (http)(custom) TAR (of TXT)
SRA Run SelectorHelp

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap